We bring payers, patients, researchers, doctors, and biotech companies together with impact investors to cure pancreatitis and other diseases. With a clear goal of measurably improving specific patient outcomes in 10 years, Mission: Cure uses innovative and cost-effective methods to develop new therapies and bring them to patients.

Bridge patient priorities and scientific research

We work to ensure that patient priorities drive research, therapy development, and care delivery. We work to apply new knowledge and evidence-based practices for the benefit of every life touched by rare and chronic diseases, such as pancreatitis.

Lead, organize, and collaborate with stakeholders to achieve shared goals

With a laser focus on measurable patient outcomes, we coordinate efforts of multiple stakeholders, including providers, researchers, payers, investors, and businesses, to commit to shared goals and execute strategies to improve patient well-being.

Incentivize patient outcomes using innovative funding models

We develop and test innovative funding models that link payment to patient outcomes such as hospitalizations, longevity, and pain to make a real difference for people suffering from the disease and increase the efficiency of healthcare systems.



will be able to prevent or treat their disease so they are no longer in pain and live longer, healthier, more productive lives.

Impact Investors

will have helped cure a disease and potentially have received a financial return.

Scientists and Clinicians

will have sufficient funding and support to pursue and succeed in their efforts to help patients and cure disease.

Healthcare and Other Payers

will be able to invest in new treatments that reduce their long‐term costs, while demonstrating their commitment to their clients’ wellbeing, by contributing to patient outcome payments.

Venture Philanthropists

will engage in what amounts to risk‐free outcome‐based philanthropy: they will not pay unless the efforts they support have delivered the results they hoped for.